Source:http://linkedlifedata.com/resource/pubmed/id/21670560
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2011-6-29
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1880-3873
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
18
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
542-3
|
| pubmed:meshHeading |
pubmed-meshheading:21670560-Apolipoprotein E2,
pubmed-meshheading:21670560-Apolipoproteins E,
pubmed-meshheading:21670560-Dyslipidemias,
pubmed-meshheading:21670560-Humans,
pubmed-meshheading:21670560-Kidney Diseases,
pubmed-meshheading:21670560-Kidney Glomerulus,
pubmed-meshheading:21670560-Lipoproteins,
pubmed-meshheading:21670560-Male,
pubmed-meshheading:21670560-Mutation
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
|
| pubmed:publicationType |
Letter,
Comment
|